CN112898192B - Preparation method of N-acyl indole compound - Google Patents
Preparation method of N-acyl indole compound Download PDFInfo
- Publication number
- CN112898192B CN112898192B CN202110186332.3A CN202110186332A CN112898192B CN 112898192 B CN112898192 B CN 112898192B CN 202110186332 A CN202110186332 A CN 202110186332A CN 112898192 B CN112898192 B CN 112898192B
- Authority
- CN
- China
- Prior art keywords
- reaction
- formula
- acyl indole
- compound
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
Abstract
本发明公开了一种N‑酰基吲哚化合物的制备方法,包括如下步骤:将钯催化剂、碳酸钾、一氧化碳替代物、2‑炔基苯胺以及芳基碘代物加入到有机溶剂中,于60℃进行反应24小时,随后加入氧化银,于60℃继续反应24小时,反应完全后,后处理得到所述的N‑酰基吲哚化合物。该制备方法操作简单,起始原料廉价易得,反应效率高,底物兼容性好,一步高效、快速合成N‑酰基吲哚化合物,便于操作的同时拓宽了此方法的实用性。The invention discloses a preparation method of N-acyl indole compound, comprising the following steps: adding palladium catalyst, potassium carbonate, carbon monoxide substitute, 2-alkynyl aniline and aryl iodide into an organic solvent, and heating at 60° C. The reaction was carried out for 24 hours, then silver oxide was added, and the reaction was continued at 60° C. for 24 hours. After the reaction was completed, the N-acyl indole compound was obtained by post-treatment. The preparation method has the advantages of simple operation, cheap and readily available starting materials, high reaction efficiency, good substrate compatibility, and efficient and rapid synthesis of N-acyl indole compounds in one step, which is convenient for operation and broadens the practicability of the method.
Description
技术领域technical field
本发明属于有机合成领域,尤其涉及一种N-酰基吲哚化合物的制备方法。The invention belongs to the field of organic synthesis, in particular to a preparation method of an N-acyl indole compound.
背景技术Background technique
吲哚是一种重要的结构骨架,广泛存在于天然产物和药物分子中。这些化合物具有抗肿瘤、抗炎、抗病毒、抗糖尿病、抗抑郁、抗高血压等活性(Chem.Rev.2010,110,4489-4497;J.Heterocyclic Chem.2010,47,491-502;Molecules,2013,18,6620-6662.)。Indole is an important structural backbone and widely exists in natural products and drug molecules. These compounds have antitumor, anti-inflammatory, antiviral, antidiabetic, antidepressant, antihypertensive and other activities (Chem. Rev. 2010, 110, 4489-4497; J. Heterocyclic Chem. 2010, 47, 491-502; , 18, 6620-6662.).
羰基化反应提供了一种直接、高效合成羰基化合物的重要方法(Chem.Rev.2019,119,2090-2127)。然而,基于羰基化反应合成N-酰基吲哚化合物的报道较少,目前应用并不广泛,但其具有较大的应用潜力,有待深入研究。The carbonylation reaction provides an important method for the direct and efficient synthesis of carbonyl compounds (Chem. Rev. 2019, 119, 2090-2127). However, there are few reports on the synthesis of N-acyl indole compounds based on the carbonylation reaction, and they are not widely used at present, but they have great application potential and need to be further studied.
基于此,我们发展了一种以2-炔基苯胺和芳基碘代物为起始原料,通过钯催化的羰基化环化反应高效、快速地合成N-酰基吲哚化合物的方法。Based on this, we have developed a method for the efficient and rapid synthesis of N-acyl indole compounds via palladium-catalyzed carbonylation cyclization using 2-alkynylanilines and aryl iodides as starting materials.
发明内容SUMMARY OF THE INVENTION
本发明提供了一种N-酰基吲哚化合物的制备方法,该制备方法步骤简单,可以兼容多种官能团,反应适用性好。The invention provides a preparation method of an N-acyl indole compound. The preparation method has simple steps, can be compatible with various functional groups, and has good reaction applicability.
一种N-酰基吲哚化合物的制备方法,包括如下步骤:将钯催化剂、碳酸钾、1,3,5-三甲酸苯酚酯(TFBen),2-炔基苯胺和芳基碘代物加入到有机溶剂中,于50~70℃进行反应20~30小时,随后加入氧化银,于50~70℃继续反应20~30小时,反应完全后,后处理得到所述的N-酰基吲哚化合物;A preparation method of N-acyl indole compound, comprising the steps of: adding palladium catalyst, potassium carbonate, 1,3,5-tricarboxylic acid phenol ester (TFBen), 2-alkynyl aniline and aryl iodide to organic In the solvent, the reaction is carried out at 50-70° C. for 20-30 hours, then silver oxide is added, and the reaction is continued at 50-70° C. for 20-30 hours. After the reaction is complete, the N-acyl indole compound is obtained by post-processing;
所述的2-炔基苯胺的结构如式(II)所示:The structure of the 2-alkynyl aniline is shown in formula (II):
所述的芳基碘代物的结构如式(III)所示:The structure of the aryl iodide is shown in formula (III):
所述的N-酰基吲哚化合物的结构如式(Ⅰ)所示:The structure of the N-acyl indole compound is shown in formula (I):
R1、R2、R3独立地为H、C1~C6烷基、C1~C6烷氧基、卤素、或者三氟甲基。R 1 , R 2 and R 3 are independently H, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halogen, or trifluoromethyl.
具体反应式如下:The specific reaction formula is as follows:
反应中可能首先经历了钯插入芳基碘代物形成芳基钯中间体,1,3,5-三甲酸苯酚酯放出的一氧化碳插入芳基钯中间体生成酰基钯中间体。其次,2-炔基苯胺与酰基钯中间体加成、还原消除得到酰胺化合物。最后,在氧化银的作用下,酰胺环化生成N-酰基吲哚化合物。In the reaction, palladium may be inserted into an aryl iodide to form an aryl palladium intermediate, and carbon monoxide released from 1,3,5-tricarboxylate phenolate is inserted into an aryl palladium intermediate to form an acyl palladium intermediate. Next, 2-alkynylaniline is added to the acylpalladium intermediate, and the amide compound is obtained by reductive elimination. Finally, under the action of silver oxide, the amides are cyclized to form N-acyl indole compounds.
本发明中,可选用的后处理过程包括:过滤,硅胶拌样,最后经过柱层析纯化得到相应的N-酰基吲哚化合物,采用柱层析纯化为本领域常用的技术手段。In the present invention, the optional post-processing process includes: filtering, mixing samples with silica gel, and finally purifying by column chromatography to obtain the corresponding N-acyl indole compound, which is a common technical means in the field.
作为优选,R1、R2、R3独立地为H、甲基、叔丁基、甲氧基、F、Cl、Br或者三氟甲基,反应的产率较高;作为进一步的优选,R1为H、F;R2为H、Me、OMe或F;R3为H、甲基、叔丁基、甲氧基、F、Cl、Br或者三氟甲基。Preferably, R 1 , R 2 , R 3 are independently H, methyl, tert-butyl, methoxy, F, Cl, Br or trifluoromethyl, and the reaction yield is high; as a further preference, R 1 is H, F; R 2 is H, Me, OMe or F; R 3 is H, methyl, tert-butyl, methoxy, F, Cl, Br or trifluoromethyl.
作为优选,所述的反应的时间为48小时,反应时间较短难以保证反应的完全。Preferably, the reaction time is 48 hours, and it is difficult to ensure the completeness of the reaction if the reaction time is short.
本发明中,作为优选,所述的有机溶剂为乙腈,此时,各种原料都能以较高的转化率转化成产物。In the present invention, preferably, the organic solvent is acetonitrile, and in this case, various raw materials can be converted into products with a relatively high conversion rate.
所述的有机溶剂的用量能将原料较好的溶解即可,1mmol的2-炔基苯胺使用的有机溶剂的量约为10mL。The amount of the organic solvent can better dissolve the raw materials, and the amount of the organic solvent used for 1 mmol of 2-alkynylaniline is about 10 mL.
作为优选,所述的钯催化剂为四(三苯基膦)钯,在众多钯催化剂中反应效率较高。Preferably, the palladium catalyst is tetrakis (triphenylphosphine) palladium, which has higher reaction efficiency among many palladium catalysts.
所述的四(三苯基膦)钯、碳酸钾、1,3,5-三甲酸苯酚酯和氧化银的摩尔比为0.1:5:5:0.5;The molar ratio of described tetrakis (triphenylphosphine) palladium, potassium carbonate, 1,3,5-tricarboxylic acid phenol ester and silver oxide is 0.1:5:5:0.5;
作为进一步的优选,所述的N-酰基吲哚化合物为式(I-1)-式(I-5)所示化合物中的一种:As a further preference, the N-acyl indole compound is one of the compounds represented by formula (I-1)-formula (I-5):
上述制备方法中,所述的四(三苯基膦)钯、氧化银、碳酸钾和芳基碘代物一般采用市售产品,都能从市场上方便地得到,所述的2-炔基苯胺可由相应的2-碘苯胺和末端芳炔快速合成得到。In the above-mentioned preparation method, the described tetrakis (triphenylphosphine) palladium, silver oxide, potassium carbonate and aryl iodide generally adopt commercially available products, which can be easily obtained from the market, and the described 2-alkynylaniline It can be rapidly synthesized from the corresponding 2-iodoaniline and terminal arylyne.
同现有技术相比,本发明的有益效果体现在:该制备方法易于操作,后处理简便;反应起始原料廉价易得,底物官能团容忍范围广,反应效率高,一步高效、快速合成出N-酰基吲哚化合物,实用性较强。Compared with the prior art, the beneficial effects of the present invention are reflected in the following: the preparation method is easy to operate, and the post-processing is convenient; the starting raw materials for the reaction are cheap and easy to obtain, the substrate functional group tolerance range is wide, the reaction efficiency is high, and the synthesis is efficient and fast in one step. N-acyl indole compounds have strong practicability.
具体实施方式Detailed ways
下面结合具体实施例对本发明做进一步的描述。The present invention will be further described below with reference to specific embodiments.
按照表1的原料配比在35mL的Schlenk管中加入四(三苯基膦)钯、碳酸钾、1,3,5-三甲酸苯酚酯、2-炔基苯胺(II)、芳基碘代物(III)和有机溶剂2mL,混合搅拌均匀,于60℃进行反应24小时,随后加入氧化银,于60℃继续反应24小时,如表1所示。反应完全后,过滤,硅胶拌样,经过柱层析纯化得到相应的N-酰基吲哚化合物(Ⅰ),反应过程如下式所示:Add tetrakis(triphenylphosphine)palladium, potassium carbonate, 1,3,5-tricarboxylate phenolate, 2-alkynylaniline (II), aryl iodide to a 35mL Schlenk tube according to the raw material ratio in Table 1 (III) and 2 mL of organic solvent, mixed and stirred uniformly, reacted at 60° C. for 24 hours, then added silver oxide, and continued to react at 60° C. for 24 hours, as shown in Table 1. After the reaction is complete, filter, mix samples with silica gel, and purify by column chromatography to obtain the corresponding N-acyl indole compound (I). The reaction process is shown in the following formula:
表1实施例1~15的原料加入量The amount of raw materials added in Table 1 Examples 1-15
表2Table 2
表1和表2中,T为反应温度,t为反应时间,Me为甲基,tBu为叔丁基,OMe为甲氧基,MeCN为乙腈。In Table 1 and Table 2, T is the reaction temperature, t is the reaction time, Me is methyl, tBu is tert-butyl, OMe is methoxy, and MeCN is acetonitrile.
实施例1~5制备得到化合物的结构确认数据:The structure confirmation data of the compounds prepared in Examples 1-5:
由实施例1制备得到的N-酰基吲哚化合物(I-1)的核磁共振(1H NMR、13C NMR)检测数据为:The nuclear magnetic resonance ( 1 H NMR, 13 C NMR) detection data of the N-acyl indole compound (I-1) prepared in Example 1 are:
1H NMR(400MHz,CDCl3):δ7.71–7.68(m,1H),7.64(d,J=8.1Hz,3H),7.42–7.37(m,2H),7.34–7.19(m,5H),7.15(d,J=8.1Hz,2H),6.85(s,1H),2.39(s,3H). 1 H NMR (400 MHz, CDCl 3 ): δ 7.71-7.68 (m, 1H), 7.64 (d, J=8.1 Hz, 3H), 7.42-7.37 (m, 2H), 7.34-7.19 (m, 5H) ,7.15(d,J=8.1Hz,2H),6.85(s,1H),2.39(s,3H).
13C NMR(100MHz,CDCl3):δ170.1,144.0,141.5,138.3,133.1,132.3,130.6,129.3,129.2,128.3,127.6,124.1,123.0,120.8,114.0,109.2,21.8. 13 C NMR (100 MHz, CDCl 3 ): δ 170.1, 144.0, 141.5, 138.3, 133.1, 132.3, 130.6, 129.3, 129.2, 128.3, 127.6, 124.1, 123.0, 120.8, 114.0, 109.2, 21.8.
由实施例2制备得到的N-酰基吲哚化合物(I-2)的核磁共振(1H NMR、13C NMR)检测数据为:The nuclear magnetic resonance ( 1 H NMR, 13 C NMR) detection data of the N-acyl indole compound (I-2) prepared in Example 2 are:
1H NMR(400MHz,CDCl3):δ7.69–7.61(m,3H),7.58–7.54(m,1H),7.37–7.32(m,2H),7.28–7.20(m,4H),7.19–7.13(m,1H),6.82–6.75(m,3H),3.81(s,3H). 1 H NMR (400 MHz, CDCl 3 ): δ 7.69–7.61 (m, 3H), 7.58–7.54 (m, 1H), 7.37–7.32 (m, 2H), 7.28–7.20 (m, 4H), 7.19– 7.13(m, 1H), 6.82–6.75(m, 3H), 3.81(s, 3H).
13C NMR(100MHz,CDCl3):δ169.4,163.6,141.4,138.3,133.1,132.9,129.3,128.3,128.2,127.6,127.2,124.0,122.8,120.8,113.8,108.8,55.6. 13 C NMR (100 MHz, CDCl 3 ): δ 169.4, 163.6, 141.4, 138.3, 133.1, 132.9, 129.3, 128.3, 128.2, 127.6, 127.2, 124.0, 122.8, 120.8, 113.8, 108.8, 55.6.
由实施例3制备得到N-酰基吲哚化合物(I-3)的核磁共振(1H NMR、13C NMR)检测数据为:The nuclear magnetic resonance ( 1 H NMR, 13 C NMR) detection data of the N-acyl indole compound (I-3) prepared from Example 3 are:
1H NMR(400MHz,CDCl3):δ7.80–7.74(m,1H),7.68–7.63(m,1H),7.57–7.52(m,2H),7.32–7.25(m,4H),7.23–7.13(m,5H),6.79(s,1H). 1 H NMR (400 MHz, CDCl 3 ): δ 7.80–7.74 (m, 1H), 7.68–7.63 (m, 1H), 7.57–7.52 (m, 2H), 7.32–7.25 (m, 4H), 7.23– 7.13(m, 5H), 6.79(s, 1H).
13C NMR(100MHz,CDCl3):δ169.1,141.1,139.2,138.2,133.6,132.9,131.7,129.3,128.6,128.45,128.43,127.9,124.6,123.5,120.9,114.2,109.8. 13 C NMR (100 MHz, CDCl 3 ): δ169.1, 141.1, 139.2, 138.2, 133.6, 132.9, 131.7, 129.3, 128.6, 128.45, 128.43, 127.9, 124.6, 123.5, 120.9, 114.2, 109.8.
由实施例4制备得到的N-酰基吲哚化合物(I-4)的核磁共振(1H NMR、13C NMR)检测数据为:The nuclear magnetic resonance ( 1 H NMR, 13 C NMR) detection data of the N-acyl indole compound (I-4) prepared in Example 4 are:
1H NMR(400MHz,CDCl3):δ7.67–7.57(m,4H),7.43(t,J=7.5Hz,1H),7.31–7.22(m,6H),6.88(t,J=8.6Hz,2H),6.74(s,1H). 1 H NMR (400MHz, CDCl 3 ): δ 7.67-7.57 (m, 4H), 7.43 (t, J=7.5Hz, 1H), 7.31-7.22 (m, 6H), 6.88 (t, J=8.6Hz) ,2H),6.74(s,1H).
13C NMR(100MHz,CDCl3):δ170.1,162.2(d,J=248.0Hz,1C),140.2,138.2,135.1,133.1,130.3,130.1(d,J=8.2Hz,1C),129.3(d,J=3.4Hz,1C),129.25,128.5,124.4,123.3,120.8,115.4(d,J=21.8Hz,1C),114.2,109.7. 13 C NMR (100 MHz, CDCl 3 ): δ 170.1, 162.2 (d, J=248.0 Hz, 1C), 140.2, 138.2, 135.1, 133.1, 130.3, 130.1 (d, J=8.2 Hz, 1C), 129.3 (d, J=3.4Hz, 1C), 129.25, 128.5, 124.4, 123.3, 120.8, 115.4 (d, J=21.8Hz, 1C), 114.2, 109.7.
由实施例5制备得到的N-酰基吲哚化合物(I-5)的核磁共振(1H NMR、13C NMR)检测数据为:The nuclear magnetic resonance ( 1 H NMR, 13 C NMR) detection data of the N-acyl indole compound (I-5) prepared in Example 5 are:
1H NMR(400MHz,CDCl3):δ7.76–7.71(m,1H),7.67–7.60(m,3H),7.39(t,J=7.4Hz,1H),7.30–7.23(m,4H),7.15–7.03(m,3H),6.93(d,J=7.4 Hz,1H),6.78(s,1H),2.24(s,3H). 1 H NMR (400 MHz, CDCl 3 ): δ 7.76-7.71 (m, 1H), 7.67-7.60 (m, 3H), 7.39 (t, J=7.4 Hz, 1H), 7.30-7.23 (m, 4H) ,7.15–7.03(m,3H),6.93(d,J=7.4 Hz,1H),6.78(s,1H),2.24(s,3H).
13C NMR(100MHz,CDCl3):δ170.3,141.5,138.3,137.8,135.3,133.0,132.8,130.2,129.4,129.3,128.4,128.3,128.2,125.5,124.3,123.2,120.8,114.2,109.3,21.4。 13 C NMR (100 MHz, CDCl 3 ): δ 170.3, 141.5, 138.3, 137.8, 135.3, 133.0, 132.8, 130.2, 129.4, 129.3, 128.4, 128.3, 128.2, 125.5, 124.3, 123.2, 120.8, 1.4.2.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110186332.3A CN112898192B (en) | 2021-02-17 | 2021-02-17 | Preparation method of N-acyl indole compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110186332.3A CN112898192B (en) | 2021-02-17 | 2021-02-17 | Preparation method of N-acyl indole compound |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112898192A CN112898192A (en) | 2021-06-04 |
CN112898192B true CN112898192B (en) | 2022-07-05 |
Family
ID=76123758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110186332.3A Active CN112898192B (en) | 2021-02-17 | 2021-02-17 | Preparation method of N-acyl indole compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112898192B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115246786B (en) * | 2021-11-30 | 2023-10-03 | 浙江理工大学 | Preparation method of indole compound or benzoxazine compound |
CN115286553B (en) * | 2022-01-05 | 2023-10-03 | 浙江理工大学 | A kind of preparation method of indole compound |
CN114539198B (en) * | 2022-02-23 | 2023-12-19 | 浙江理工大学 | Preparation method of amide compound containing (hetero)chroman structure |
CN115260080B (en) * | 2022-07-01 | 2023-10-20 | 浙江理工大学 | Preparation method of indole-3-formamide compound |
CN115677674B (en) * | 2022-08-25 | 2025-02-18 | 浙江理工大学 | A method for preparing a heterocyclic compound containing indole ketone and 3-acylbenzofuran or indole structure |
CN115403505B (en) * | 2022-09-02 | 2024-09-03 | 浙江理工大学 | A method for preparing a thioester compound containing an indole ketone structure |
-
2021
- 2021-02-17 CN CN202110186332.3A patent/CN112898192B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN112898192A (en) | 2021-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112898192B (en) | Preparation method of N-acyl indole compound | |
CN114195711B (en) | Preparation method of quinoline-4 (1H) -ketone compound | |
CN113045489B (en) | Preparation method of 3-arylquinoline-2 (1H) ketone derivative | |
CN114539198B (en) | Preparation method of amide compound containing (hetero)chroman structure | |
CN115260080B (en) | Preparation method of indole-3-formamide compound | |
CN114773242A (en) | Preparation method of alpha, beta-unsaturated thioester compound | |
CN112939780B (en) | A kind of synthetic method of indanone derivatives | |
CN110878099B (en) | Preparation method of pyrrole [1,2, alpha ] indole alkaloid derivative | |
CN115286553B (en) | A kind of preparation method of indole compound | |
CN112812032A (en) | Preparation method of acetamide compound | |
CN112694430B (en) | A kind of preparation method of 1,5-dihydro-2H-pyrrole-2-one compound | |
CN109232529B (en) | Preparation method of Rh (III) catalytic compound with nitrogen heterocyclic skeleton | |
CN111978194B (en) | Preparation method of aryl acetamide compound | |
CN115246786B (en) | Preparation method of indole compound or benzoxazine compound | |
CN112239456B (en) | A kind of preparation method of substituted 2,3-dihydroquinolone compound | |
CN114751883B (en) | Preparation method of benzofuran-3-carboxamide compound | |
CN115286628B (en) | Preparation method of indolo[2,1a]isoquinoline compound | |
CN116640146A (en) | A kind of preparation method of trifluoromethyl substituted chromonoquinoline | |
CN113735826A (en) | Preparation method of 3-benzylidene-2, 3-dihydroquinolone compound | |
CN115403505B (en) | A method for preparing a thioester compound containing an indole ketone structure | |
CN113896648B (en) | Preparation method of alpha, beta-unsaturated amide compound | |
CN115353482B (en) | Preparation method of trifluoromethyl and selenium substituted azaspiro [4,5] -tetraenone compound | |
CN116640121A (en) | Preparation method of trifluoroacetyl substituted indoline compound | |
CN117164506A (en) | Preparation method of indeno [1,2-b ] indol-10 (5H) -one compound | |
CN119823040A (en) | Preparation method of amido-containing 3, 4-dihydro-isoquinoline-1 (2H) -ketone derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |